Asthma Drug Xolair Is Being Investigated By FDA For Possible Cardiac Problems - Drug Injury Watch
Links shared publicly online about this topic.
- 1,729total visits
Asthma Drug Xolair Is Being Investigated By FDA For Possible Cardiac Problems - Drug Injury Watch
Serious Side Effects Include Heart Attacks, Abnormal Heart Rhythms, Heart Failure, And Various Conditions Caused By Blood Clots (Posted by Tom Lamb at DrugInjuryWatch.com) By means of a July 16, 2009 MedWatch Email Alert we first learned about an ongoing FDA investigation of Xolair (omalizumab): FDA is evaluating interim safety findings from an ongoing study of Xolair (omalizumab) titled Evaluating the Clinical Effectiveness and Long-Term Safety in Patients with Moderate to Severe Asthma (EXCELS
View full resource at drug-injury.com
Tags: Asthma, Asthma Medication, Heart, Heart Disease, Heart Attack, Drug, FDA, Xolair
Most Recently Shared on September 23, 2009 at 12:28 am By:
Asthma Drug Xolair Is Being Investigated By FDA For Possible Cardiac Problems http://bit.ly/C1DPq
Advertisement
